search icon
sbio-img

Alps medical breakthroughs etf share price

SBIO
PCQ
$66.086
-$1
(-1.5%)
Provider: ALPS Category: Health

Price chart

Key metrics

Expense Ratio info-icon
The expense ratio is how much you pay a mutual fund or ETF per year, expressed as a percent of your investments. It is a measure of the fund's operating costs relative to assets.
0.5%
Volume info-icon
This is the total number of shares traded during the most recent trading day.
5.21K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.97
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$34.88 L
$70.85 H
$66.086

About alps medical breakthroughs etf, etf

The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. more

Provider: ALPSCategory: Health

Returns

Time FrameSBIOS&P500
1-Week Return-2.92%0.5%
1-Month Return5.62%3.86%
3-Month Return23.76%1.92%
6-Month Return31.86%12.03%
1-Year Return90.76%18.56%
3-Year Return126.84%73.83%
5-Year Return44.71%70.11%
10-Year Return175.86%252.93%

Largest holdings

Stock name Ticker Weight
CRNX-img Crinetics Pharmaceuticals Inc.
CRNX
4.57%
APGE-img Apogee Therapeutics Inc.
APGE
4.27%
CGON-img CG oncology Inc.
CGON
3.35%
TVTX-img Travere Therapeutics Inc.
TVTX
3.12%
XENE-img Xenon Pharmaceuticals Inc.
XENE
2.96%
DNTH-img Dianthus Therapeutics Inc.
DNTH
2.96%
ORKA-img Oruka Therapeutics Inc.
ORKA
2.81%
ACAD-img ACADIA Pharmaceuticals Inc.
ACAD
2.55%
EWTX-img Edgewise Therapeutics Inc.
EWTX
2.35%
DFTX-img Definium Therapeutics Inc.
DFTX
2.28%
DYN-img Dyne Therapeutics Inc.
DYN
2.12%
RLAY-img Relay Therapeutics Inc.
RLAY
2.09%
MANE-img VeraDermics Inc.
MANE
2.09%
AMLX-img Amylyx Pharmaceuticals Inc.
AMLX
1.98%
DNLI-img Denali Therapeutics Inc.
DNLI
1.95%
IDYA-img Ideaya Biosciences Inc.
IDYA
1.8%
GPCR-img Structure Therapeutics Inc.
GPCR
1.72%
IMNM-img Immunome Inc.
IMNM
1.6%
TARS-img Tarsus Pharmaceuticals Inc.
TARS
1.57%
CLDX-img Celldex Therapeutics Inc.
CLDX
1.57%
IRON-img Disc Medicine Inc.
IRON
1.56%
NAMS-img Newamsterdam Pharma Co. NV
NAMS
1.55%
MBX-img MBX Biosciences Inc.
MBX
1.53%
ZLAB-img Zai Lab Ltd.
ZLAB
1.45%
VRDN-img Viridian Therapeutics Inc.
VRDN
1.3%
BCRX-img BioCryst Pharmaceuticals Inc.
BCRX
1.28%
SLS-img SELLAS Life Sciences Group Inc.
SLS
1.26%
VERA-img Vera Therapeutics Inc.
VERA
1.25%
NKTR-img Nektar Therapeutics
NKTR
1.25%
RAPP-img Rapport Therapeutics Inc.
RAPP
1.19%
NUVB-img Nuvation Bio Inc.
NUVB
1.19%
MLYS-img Mineralys Therapeutics Inc.
MLYS
1.15%
SRPT-img Sarepta Therapeutics Inc.
SRPT
1.12%
PVLA-img Palvella Therapeutics Inc.
PVLA
1.09%
KLRA-img Kailera Therapeutics Inc.
KLRA
1.07%
VCEL-img Vericel Corp.
VCEL
1.07%
AGIO-img Agios Pharmaceuticals Inc.
AGIO
1.01%
STOK-img Stoke Therapeutics Inc.
STOK
1.01%
ZBIO-img Zenas Biopharma Inc.
ZBIO
1.01%
GENB-img Generate Biomedicines Inc.
GENB
1%
XNCR-img Xencor Inc.
XNCR
0.98%
LKFT-img Lakefront Biotherapeutics NV
LKFT
0.96%
IMCR-img Immunocore Holdings PLC
IMCR
0.95%
CMPS-img Compass Pathways PLC
CMPS
0.95%
TSHA-img Taysha Gene Therapies Inc.
TSHA
0.85%
BCAX-img Bicara Therapeutics Inc.
BCAX
0.78%
MAZE-img Maze Therapeutics Inc.
MAZE
0.78%
TYRA-img Tyra Biosciences Inc.
TYRA
0.76%
AVBP-img ArriVent Biopharma Inc.
AVBP
0.72%
LBRX-img LB Pharmaceuticals Inc.
LBRX
0.7%
SPTX-img Seaport Therapeutics Inc.
SPTX
0.66%
MGTX-img MeiraGTx Holdings PLC
MGTX
0.65%
IMTX-img Immatics NV
IMTX
0.65%
ANRO-img Alto Neuroscience Inc.
ANRO
0.63%
MNKD-img MannKind Corp.
MNKD
0.62%
VOR-img Vor BioPharma Inc.
VOR
0.62%
CRVS-img Corvus Pharmaceuticals Inc.
CRVS
0.61%
KURA-img Kura Oncology Inc.
KURA
0.58%
GERN-img Geron Corp.
GERN
0.5%
WVE-img Wave Life Sciences Inc.
WVE
0.49%
SLDB-img Solid Biosciences Inc.
SLDB
0.49%
CADL-img Candel Therapeutics Inc.
CADL
0.49%
DSGN-img Design Therapeutics Inc.
DSGN
0.48%
OLMA-img Olema Pharmaceuticals Inc.
OLMA
0.46%
TBPH-img Theravance Biopharma Inc.
TBPH
0.45%
RIGL-img Rigel Pharmaceuticals Inc.
RIGL
0.44%
SGP-img SpyGlass Pharma Inc.
SGP
0.44%
ACRS-img Aclaris Therapeutics Inc.
ACRS
0.43%
CLYM-img Climb Bio Inc.
CLYM
0.43%
FDMT-img 4D Molecular Therapeutics Inc.
FDMT
0.39%
OCS-img Oculis Holding AG
OCS
0.36%
ALLO-img Allogene Therapeutics Inc.
ALLO
0.36%
TECX-img Tectonic Therapeutic Inc.
TECX
0.34%
AGMB-img AgomAb Therapeutics NV
AGMB
0.33%
ALT-img Altimmune Inc.
ALT
0.31%
EIKN-img Eikon Therapeutics Inc.
EIKN
0.3%
NGNE-img Neurogene Inc.
NGNE
0.3%
DCTH-img Delcath Systems Inc.
DCTH
0.29%
CTNM-img Contineum Therapeutics Inc.
CTNM
0.29%
FLGT-img Fulgent Genetics Inc.
FLGT
0.29%
ZURA-img Zura Bio Ltd.
ZURA
0.28%
EVMN-img Evommune Inc.
EVMN
0.24%
RLMD-img Relmada Therapeutics Inc.
RLMD
0.23%
RZLT-img Rezolute Inc.
RZLT
0.23%
CMPX-img Compass Therapeutics Inc.
CMPX
0.22%
ARCT-img Arcturus Therapeutics Holdings Inc.
ARCT
0.22%
CCCC-img C4 Therapeutics Inc.
CCCC
0.22%
ENTA-img Enanta Pharmaceuticals Inc.
ENTA
0.2%
XFOR-img X4 Pharmaceuticals Inc.
XFOR
0.2%
UPB-img Upstream Bio Inc.
UPB
0.19%
IMRX-img Immuneering Corp.
IMRX
0.17%
IKT-img Inhibikase Therapeutics Inc.
IKT
0.16%
SABS-img SAB Biotherapeutics Inc.
SABS
0.15%
AVXL-img Anavex Life Sciences Corp.
AVXL
0.14%
SION-img Sionna Therapeutics Inc.
SION
0.14%
MGNX-img MacroGenics Inc.
MGNX
0.13%
FULC-img Fulcrum Therapeutics Inc.
FULC
0.13%
AKBA-img Akebia Therapeutics Inc.
AKBA
0.12%
TARA-img Protara Therapeutics Inc.
TARA
0.11%
NBP-img NovaBridge Biosciences
NBP
0.11%
BCYC-img Bicycle Therapeutics PLC
BCYC
0.11%
IMUX-img Immunic Inc.
IMUX
0.11%
TENX-img Tenax Therapeutics Inc.
TENX
0.03%
Novo.Nordisk.A.S-img Novo Nordisk A/S
Novo.Nordisk.A.S
0%
AstraZeneca.PLC-img AstraZeneca PLC
AstraZeneca.PLC
0%
Chinook.Therapeutics.Inc.-img Chinook Therapeutics Inc.
Chinook.Therapeutics.Inc.
0%
USD-img Cash Equivalent
USD
-0.01%

Sector breakdown

Sector Weight
Health care
100.00%

Faqs

What is ALPS Medical Breakthroughs ETF (SBIO) ETF share price today?

ALPS Medical Breakthroughs ETF (SBIO) share price today is $66.086.

Can Indians buy ALPS Medical Breakthroughs ETF shares?

Yes, Indians can buy shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. To buy SBIO from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.

Can Fractional shares of ALPS Medical Breakthroughs ETF be purchased?

Yes, you can purchase fractional shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. You can start investing in ALPS Medical Breakthroughs ETF (SBIO) with a minimum investment of $1.

How to invest in ALPS Medical Breakthroughs ETF shares from India?

  • Click on Sign Up or Invest in SBIO ETF at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ALPS Medical Breakthroughs ETF shares

What is ALPS Medical Breakthroughs ETF's 52-week high and low ETF share price?

The 52-week high price of ALPS Medical Breakthroughs ETF (SBIO) is $70.85. The 52-week low price of ALPS Medical Breakthroughs ETF (SBIO) is $34.88.

What is ALPS Medical Breakthroughs ETF's ticker or symbol?

The stock symbol (or ticker) of ALPS Medical Breakthroughs ETF is SBIO.

Can I set up automatic investments (SIP) in ALPS Medical Breakthroughs ETF shares?

Yes, you can setup SIP in ALPS Medical Breakthroughs ETF shares. Follow the below steps to create the SIP:

  • Sign up on Vested and complete your KYC for US Stocks
  • Transfer funds to your US Stocks account
  • Navigate to SBIO tickr page and set up your recurring investment

What is the historical performance of ALPS Medical Breakthroughs ETF ETF?

Here is the historical performance of SBIO on the Vested app.

  • 1 Year Return - {X%}
  • 3 Year Return
  • 5 Year
  • You can also access the top holdings, the expense ratio, and the sector breakdown for ALPS Medical Breakthroughs ETF on Vested.

What is the expense ratio of ALPS Medical Breakthroughs ETF?

The expense ratio of ALPS Medical Breakthroughs ETF (SBIO) is 0.5%.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top